Boston Scientific Corporation

DB:BSX Stock Report

Market Cap: €125.2b

Boston Scientific Past Earnings Performance

Past criteria checks 4/6

Boston Scientific's earnings have been declining at an average annual rate of -21%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 9.1% per year. Boston Scientific's return on equity is 8.5%, and it has net margins of 11.3%.

Key information

-21.0%

Earnings growth rate

-22.4%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate9.1%
Return on equity8.5%
Net Margin11.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Boston Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:BSX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2415,9111,7935,7511,519
30 Jun 2415,2291,8285,4301,468
31 Mar 2414,7071,7655,3391,443
31 Dec 2314,2401,5705,1901,414
30 Sep 2313,7571,1914,9741,381
30 Jun 2313,4008614,8651,364
31 Mar 2313,0458464,6751,341
31 Dec 2212,6826424,5201,323
30 Sep 2212,5675964,5101,313
30 Jun 2212,3298284,4451,284
31 Mar 2212,1627544,4001,247
31 Dec 2111,8889854,3591,204
30 Sep 2111,4701,1014,1821,166
30 Jun 2111,1965264,0991,171
31 Mar 2110,1222013,7771,115
31 Dec 209,913-1153,7871,143
30 Sep 2010,1083,6853,8641,165
30 Jun 2010,1573,9803,8921,157
31 Mar 2010,7854,2874,0621,194
31 Dec 1910,7354,7003,9281,174
30 Sep 1910,3921,0903,7901,154
30 Jun 1910,0771,3963,6481,136
31 Mar 199,9371,7973,5661,132
31 Dec 189,8231,6713,5571,113
30 Sep 189,6706703,4981,088
30 Jun 189,5005213,4241,053
31 Mar 189,2671123,3501,023
31 Dec 179,0481043,281997
30 Sep 178,8318433,227990
30 Jun 178,7147883,199969
31 Mar 178,5824353,163945
31 Dec 168,3863473,083920
30 Sep 168,095813,029908
30 Jun 167,878-3452,979895
31 Mar 167,595-362,898894
31 Dec 157,477-2392,847876
30 Sep 157,314-3962,819840
30 Jun 157,272-1552,836832
31 Mar 157,302-2532,883818
31 Dec 147,308-1192,878817
30 Sep 147,2582882,849826
30 Jun 147,1472402,766831
31 Mar 147,0833662,680848
31 Dec 137,070-1212,651861

Quality Earnings: BSX has high quality earnings.

Growing Profit Margin: BSX's current net profit margins (11.3%) are higher than last year (8.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: BSX's earnings have declined by 21% per year over the past 5 years.

Accelerating Growth: BSX's earnings growth over the past year (50.5%) exceeds its 5-year average (-21% per year).

Earnings vs Industry: BSX earnings growth over the past year (50.5%) exceeded the Medical Equipment industry 10.1%.

Return on Equity

High ROE: BSX's Return on Equity (8.5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 17:37
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Boston Scientific Corporation is covered by 70 analysts. 32 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
David RescottBaird
Ishan MajumdarBaptista Research